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The Critical Role of Lymph Nodes in Corneal
Alloimmunization and Graft Rejection
Satoru Yamagami1,2 and M. Reza Dana1
PURPOSE. To elucidate the role of draining cervical lymph nodes
(CLNs) in corneal alloimmunity.
METHODS. Fully mismatched orthotopic corneal transplantation
was performed in BALB/c hosts that had their CLNs excised
before transplantation (CLN2). Normal hosts (CLN1), splenec-
tomized mice (Sp2), and those without either CLNs or spleen
(CLN2/Sp2) served as comparison groups. To determine the
contribution of CLNs to alloimmunity more directly, CLN2
mice were reconstituted by grafting LNs from other BALB/c
mice to their cervical lymphatic chains, thus deriving CLN2/1
mice. Tetramethyl rhodamine isothiocyanate’s (TRITC) flow to
draining CLNs was used as a measure of afferent lymph flow.
Graft survival and allospecific delayed-type hypersensitivity
(DTH) were used as measures of alloreactivity.
RESULTS. Fifty percent of normal control and 12% of Sp2 hosts
accepted the allografts. In contrast, 100% of CLN2 and 88% of
CLN2/Sp2 hosts accepted allografts indefinitely (P , 0.01).
Additionally, all CLN2 hosts failed to demonstrate allospecific
DTH (P , 0.001). CLN2/1 mice reconstituted with LN from
naı¨ve animals showed graft survival rates and DTH responses
that were indistinguishable from those of naı¨ve CLN1 mice. Of
particular interest, however, is that mice reconstituted with
CLNs from hosts with rejected corneal grafts had swift rejec-
tion of subsequent corneal grafts and exhibited strong donor-
specific DTH. In contrast, mice reconstituted with CLNs from
hosts with accepted corneal grafts showed rejection of subse-
quent corneal grafts in a manner that was indistinguishable
from rejection in naı¨ve CLN1 hosts.
CONCLUSIONS. Draining CLNs play a critical role in allosensitiza-
tion and rejection. In contrast to the spleen, draining CLNs do
not appear to play a critical role in tolerance induction in
corneal transplantation. (Invest Ophthalmol Vis Sci. 2001;42:
1293–1298)
Corneal transplantation represents, by far, the most com-mon form of organ allotransplantation in the world. In the
United States alone, nearly 40,000 corneal grafts are performed
annually.1 Most corneal allografts performed in low-risk hosts
without ocular inflammation survive indefinitely under cover
of topical corticosteroid therapy. However, this therapy is
commonly associated with serious side effects including glau-
coma, cataracts, and opportunistic infection. Moreover, the
survival of high-risk corneal transplants performed in inflamed
host beds, which is an increasingly common indication, is well
below 50%, even with the use of local and systemic immuno-
suppressive therapy.2,3 Therefore, determining the mecha-
nisms of corneal transplant rejection is a priority in ocular
immunology research.
Cervical lymph nodes (CLNs) drain the head and facial
region, including the eyes,4,5 and have been implicated in both
mucosal antigen-specific immunization and tolerance.5–8 In a
classic series of experiments Wolvers et al.7 showed that the
induction of immunologic tolerance to intranasal antigens is
fully dependent on the presence of the native cervical LNs and
that this tolerance induction cannot be replaced by peripheral
(noncervical) LNs transplanted to the same site. Although it is
known that CLNs also receive afferent lymphatics from the
ocular compartment5 and that alloreactive cytotoxic T cells are
generated in draining CLNs after high-risk corneal transplanta-
tion,9 the functional role of CLNs in the graft rejection process
has not been directly studied. Moreover, because a number of
secondary lymphoid organs, including the spleen, are involved
in generation of allospecific responses,10,11 the direct contri-
bution of CLNs to corneal alloimmunity remains to be deter-
mined. Finally, it has remained unclear whether the alloim-
mune response generated to corneal grafts in CLNs is primarily
sensitizing or tolerance-inducing—that is, whether the overall
in vivo effect of the donor-specific response generated in CLNs
after transplantation promotes graft rejection or acceptance.
In the present study we investigated the role of CLNs in
corneal alloimmunity, first by excising them from transplant-
recipient mice (CLN2) and comparing graft survival and gen-
eration of donor (allo)-specific delayed-type hypersensitivity
(DTH) to intact hosts endowed with their native CLNs (CLN1).
In addition, CLN2 mice were reconstituted by grafting LNs
from other syngeneic naı¨ve animals or from syngeneic mice
that had previously been corneally graft recipients, to deter-
mine whether the functional role of the CLNs could be rees-
tablished and whether allospecific (graft-destructive or toler-
ance-inducing) immunity could be adoptively transferred. In
the aggregate, our data strongly suggest that CLNs, in contrast
to the spleen, which plays a principal role in tolerance induc-
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Orthotopic Corneal Transplantation and
Definition of Graft Rejection
Orthotopic penetrating keratoplasty was performed as described pre-
viously in one (right) eye of each mouse.12 Briefly, after induction of
mydriasis, the recipient host bed was marked with a trephine and
excised with microscissors to a size of 1.5 mm. The donor cornea was
excised with a 2.0-mm trephine (Storz, St. Louis, MO) and transplanted
into the host corneal bed with interrupted 11-0 nylon sutures (Shar-
point, Vanguard, TX). The corneal sutures were removed 7 days after
surgery. Eyes with the complication of postoperative cataract, infec-
tion, or anterior synechiae formation were excluded from the study.
The corneal grafts were observed weekly by slit lamp biomicroscopy.
Grafts were defined as rejected when they became opaque and the iris
details could not be recognized clearly using a standardized opacity-
grading scheme. Kaplan–Meier analysis was adopted to construct sur-
vival curves, and the log-rank test was used to compare the probability
of corneal graft survival in different settings. P , 0.05 was considered
significant.
Surgical Removal of CLNs and Spleen
After induction of deep anesthesia, a small incision was made in the
neck skin under the operating microscope, and the superficial cervical
and facial LNs (usually two to three each) were removed bilaterally for
generation of LN-deficient CLN2 mice. The incision was then closed
with several 8-0 nylon sutures. Splenectomy was performed similarly,
and the skin wound closed with 8-0 nylon sutures. Concurrent removal
of both spleen and CLNs (CLN2/Sp2) or splenectomy alone (Sp2) was
performed in some (n 5 8, each group) mice. In separate experiments
not involving transplantation, CLN2 mice were examined at various
time points (2 to 8 weeks after LN excision) to ensure that the
technique had led to indefinite loss of lymphatic flow to the cervical
area. For the experiments described herein, unless otherwise noted,
CLN2 mice were used for corneal transplantation at least 4 weeks after
LN excision.
Assay for DTH
To evaluate the allospecific cell-mediated immune response in CLN2
mice, DTH responses were determined by an ear-swelling assay. Five
weeks after grafting, splenocytes from donor B6 mice were irradiated
(30 Gy), resuspended at a concentration of 1 3 106 in 10 ml phosphate-
buffered saline (PBS), and injected into the right ear pinnae of hosts.
PBS was injected as a control in the left ear pinnae. After 24 hours, ear
thickness was measured with a low-pressure micrometer (Mitsutoyo,
Tokyo, Japan). DTH-dependent ear swelling was calculated according
to the following formula: specific ear swelling 5 [(24-hour measure-
ment of right ear 2 0-hour measurement of right ear) 2 (24-hour
measurement of left ear 2 0-hour measurement of left ear)] 3 1023
mm. Similar measurements were made at 48 hours. All measurements
were performed in a masked fashion, and all experiments were re-
peated at least once. The unpaired t-test was used to compare the DTH
responses. P , 0.05 was considered significant.
Transplantation of LNs to the Cervical Lymphatic
Chain and Analysis of Lymph Flow
Cervical and facial LNs, or popliteal and inguinal LNs, were harvested
from BALB/c mice for transplantation to the cervical lymphatic chains
of CLN2 mice to derive reconstituted CLN2/1 mice, as previously
described.7 In summary, donor LNs were aseptically collected by use
of an operating microscope and placed on chilled sterile RPMI 1640
until transfer to another mouse. After the mice were anesthetized and
the bilateral CLNs removed, as detailed earlier, to derive CLN2 mice,
mice were reconstituted by placing either orthotopic (CLN) or heter-
otopic (inguinal or popliteal) LNs onto to each side of the trachea of
CLN2 mice, thereby deriving CLN2/1 mice. In all cases, one LN was
placed on either side of the cervical lymphatic chain, as previously
described.7
To determine whether there is afferent lymphatic flow from the eye
to the grafted LNs, 5 ml (25 mg/5 ml) tetramethyl rhodamine isothio-
cyanate (TRITC; Sigma, St. Louis, MO) was injected into the subcon-
junctival space of one (right) eye of reconstituted CLN2/1 mice at 2, 4,
and 8 weeks after LN transplantation. One hour after TRITC injection,
the (native or grafted) CLNs were removed and embedded in optimal
cutting temperature (OCT) compound (Miles, Elkhart, IN). Frozen
specimens were sectioned at 9 mm by cryostat. The tissues were
mounted on glass slides and observed for fluorescence by a fluores-
cence microscope. LNs of mice that received subconjunctival injec-
tions of PBS instead of TRITC were used for negative control animals,
and naı¨ve CLN1 mice served as positive control animals (n 5 5 LNs per
group). The amount of TRITC in the LNs, as a measure of afferent
lymph flow, was graded in a masked fashion and without knowledge of
the source of the LNs in each of 10 sections through the center of the
node per time point studied. The number of TRITC1 cells per 3200
field were averaged for each time point.
Harvesting of CLNs for Transplantation into
BALB/c Mice from Syngeneic Corneal
Graft Recipients
Once we established how long it took (4 weeks, as detailed later) to
re-establish normal lymphatic flow from the eye to grafted LNs in CLN2
mice, we sought to determine the effect of grafting LNs from hosts of
either rejected or accepted corneal grafts to syngeneic CLN2 mice to
create reconstituted CLN2/1 hosts that subsequently received alloge-
neic corneal grafts. Accordingly, BALB/c mice that received either
accepted or rejected C57BL/6 corneal grafts were killed 8 weeks after
corneal transplantation, for harvesting of their CLNs. The harvested
LNs were then transplanted into naı¨ve CLN2 mice, as detailed earlier.
After 4 weeks, allogeneic C57BL/6-derived corneas were orthotopically
grafted to the reconstituted CLN2/1 hosts and observed for 12 weeks
for graft survival.
RESULTS
Clinical Course of Host Allograft Recipients with
or without CLN
Figure 1 shows the survival curve of corneal allografts in naı¨ve
CLN1 (control), LN-deficient (CLN2), splenectomized (Sp2),
and LN-deficient and splenectomized (CLN2/Sp2) hosts. Of
the control mice with native CLNs, 50% showed rejection of
the corneal grafts by 6 weeks after transplantation, whereas
50% had grafts that remained transparent without any sign of
rejection by 12 weeks after surgery. In contrast, none of the
transplants grafted onto CLN2 hosts (n 5 12) showed rejection
(P , 0.001). Because induction of tolerance has been related to
the functional presence of the oculosplenic axis,13,14 graft
survival was also assessed in splenectomized hosts to contrast
with graft survival results among CLN2 hosts. Fifty percent of
Sp2 hosts (n 5 8) showed swift rejection of the allograft by 2
weeks after transplantation and 88% by 5 weeks, significantly
exceeding rejection rates in normal control animals (P , 0.01).
By contrast, only one of eight allografts in splenectomized
LN-deficient (CLN2/Sp2) hosts showed rejection (P , 0.05),
suggesting that from a graft-survival standpoint, the beneficial
effect of lymph node deficiency offset the detrimental effect of
splenectomy on graft survival.
Allospecific DTH Assay
To compare the induction of allospecific immunity among the
various (CLN1, CLN2, CLN2/Sp2) hosts, irradiated donor
splenocytes were injected into the ear pinnae of grafted mice
to elicit donor-specific swelling. Naı¨ve non–graft-recipient
mice were used as negative control animals, and BALB/c mice
subcutaneously (SC) immunized to B6 splenocytes were used
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as positive control animals (n 5 5 animals per group in each
protocol). Grafted CLN1, but not naı¨ve, mice exhibited strong
DTH alloreactivity to donor alloantigens in the fifth week after
transplantation (Fig. 2A, P , 0.05). In contrast, the allospecific
DTH response among CLN2 mice (Fig. 2B) was profoundly
lower than in positive control animals (P , 0.001) and was
indistinguishable from that in naı¨ve control animals, suggesting
failure in induction of allosensitization in the LN-deficient
mice. The response among CLN2/Sp2 mice was indistinguish-
able from that seen in CLN2 mice with intact spleens (data not
shown), similarly showing failure of generation of donor-spe-
cific DTH associated with loss of CLN.
Analysis of Lymphatic Flow to CLN
To evaluate lymphatic flow to grafted LNs, TRITC was injected
into the subconjunctiva of one eye of each CLN2/1 animal. At
specified time points, the grafted LNs were harvested and
assayed for fluorescence. Injection of TRITC into eyes of naı¨ve
animals with native LNs served as a control treatment. One
hour after injection of TRITC, easily appreciable fluorescence
(mean 6 SD: 28 6 8 TRITC1 cells per field) was easily detected
in sections through the ipsilateral (but not contralateral) CLNs
harvested from control animals with their native CLNs. In
contrast, CLNs harvested from reconstituted CLN2/1 mice
exhibited only trace fluorescence (9 6 4 TRITC1 cells per
field; P , 0.002 compared with control animals) by 2 weeks
after LN transplantation, suggesting that normal functional lym-
phatic flow had not yet been established at that time point.
However, by 4 weeks after LN transplantation, normal fluores-
cence (30 6 9 TRITC1 cells per field) was again readily de-
tectable in the grafted CLNs at levels indistinguishable from
that seen in control animals with native CLNs. Similar results
(34 6 7 TRITC1 cells) were observed at 8 weeks after LN
transplantation.
Clinical Course of Corneal Allografts in
Reconstituted Mice
The data presented demonstrate the association between fail-
ure in induction of allospecific DTH and enhanced graft sur-
vival in CLN2 mice and the reestablishment of normal lym-
phatic flow to LNs grafted to the cervical chain. To confirm
that it is the presence of LNs per se that promotes alloreactiv-
ity, reconstituted (CLN2/1) mice were derived by grafting
syngeneic LNs to the cervical chain of CLN2 mice. Moreover,
to determine whether the contribution of CLNs to alloimmu-
nity is site specific, both orthotopic (cervical) and heterotopic
(inguinal–popliteal) nodes were harvested for transfer as de-
tailed. Because we had established that it takes 4 weeks for
reestablishment of lymphatic flow to the grafted LNs, CLN2/1
mice became hosts to C57BL/6 corneal allografts 4 weeks after
LN transplantation (Fig. 3). Kaplan–Meier survival analysis re-
vealed that reconstituted CLN2/1 mice experienced rejection
of their corneal allografts in a manner indistinguishable from
that in intact CLN1 control animals, irrespective of the origin
of the grafted LNs. Accordingly, allografts were rejected in 5
FIGURE 1. Corneal graft survival was enhanced in LN-deficient hosts.
Kaplan–Meier survival curves for corneal allografts performed in naı¨ve
CLN1 (n 5 24), LN-deficient (n 5 12), splenectomized (Sp2; n 5 8),
or LN-deficient and splenectomized (CLN2/Sp2; n 5 8) hosts. Fifty
percent of naı¨ve mice with native CLNs showed rejection of their
corneal allografts. CLN2 hosts demonstrated universal and indefinite
graft survival (P , 0.001); similarly, only 12.5% of CLN2/Sp2 hosts had
rejection of their grafts (P , 0.05). In contrast, grafts were rejected in
87.5% of Sp2 hosts with normal CLNs by 5 weeks, far exceeding those
in either CLN2 or control hosts (P , 0.01). Control, naı¨ve BALB/c host
group; LN(2), LN-deficient host group; SP(2), splenectomized host
group; Sp(2)LN(2), splenectomized LN-deficient host group.
FIGURE 2. LN-deficient hosts failed to generate donor-specific DTH.
Allospecific DTH in mice, with, or without CLNs, 5 weeks after corneal
transplantation (n 5 5 per group in each bar). (A) Mice with intact
native lymph nodes (CLN1), similar to positive control animals, exhib-
ited significant DTH responses to donor alloantigens compared with
negative control animals (*P 5 0.04). (B) Allospecific DTH response in
CLN2 hosts, similar to naı¨ve control animals, was markedly suppressed
compared with that in positive control animals (**P , 0.001).
FIGURE 3. Graft survival in reconstituted host recipients of trans-
planted syngeneic naı¨ve LNs. Kaplan–Meier survival curves for corneal
allografts performed in reconstituted CLN2/1 hosts with grafted nodes
that originated either orthotopically (CLN; n 5 10) or heterotopically
(inguinal/popliteal; n 5 12). Graft survival rates were 50% in the
orthotopic and 42% in the heterotopic group, consistent with that seen
in normal CLN1 hosts (P . 0.6) and significantly lower than that
observed in CLN2 hosts (Fig. 1). Control, naı¨ve CLN1 hosts; CLN TP,
CLN2/1 mice with orthotopically grafted CLN; HLN TP, CLN2/1 mice
with heterotopically grafted LNs.
IOVS, May 2001, Vol. 42, No. 6 Lymph Nodes in Corneal Alloimmunity 1295
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/933221/ on 06/18/2017
(50%) of 10 of the reconstituted CLN2/1 mice receiving ortho-
topic LNs and in 7 (58%) of 12 CLN1 hosts receiving hetero-
topic LNs. In either case, the rapidity and rate of corneal graft
rejection was identical with that seen in CLN1 control animals.
Having established that functional drainage to CLNs is crit-
ical in allosensitization and that CLN2 mice reconstituted with
transplanted LNs are capable of generating alloreactivity, we
tested the hypothesis that CLNs transplanted from corneal graft
recipients that have had rejection of their corneal allografts are
more effective in subsequent corneal graft rejection than CLNs
transplanted from recipients with accepted corneal grafts. Ac-
cordingly, CLNs were harvested from mice with rejected (n 5
8) or accepted (n 5 10) corneal grafts 8 weeks after transplan-
tation and grafted orthotopically into the cervical lymphatic
chain of CLN2 mice. Four weeks later, the reconstituted
CLN2/1 mice received C57BL/6 corneal allografts. Positive
control animals were normal mice that were presensitized
before corneal transplantation by SC immunization with
C57BL/6-derived splenocytes; naı¨ve intact CLN1 mice served
as negative control animals. The data show that 40% of the
reconstituted CLN2/1 mice receiving CLNs originating from
mice with accepted corneal grafts had rejection of their cor-
neal allografts—comparable to the rejection rate seen in naı¨ve
CLN1 mice (Fig. 4).
Thus, it is important to note that grafting CLNs from ac-
cepted corneal graft recipients did not bias subsequent graft
survival among reconstituted hosts, positively or negatively. In
contrast, hosts reconstituted with CLNs from mice that had had
rejection of their corneal transplants had universal rejection of
their corneal allografts. In fact, the rapidity of rejection in this
host group was similar to that seen in hosts that were sensi-
tized to donor splenocytes by SC immunization before corneal
transplantation, reflecting the functional adoptive transfer of
alloreactivity with LN transplantation.
Allospecificity of CLN Transplantation
We conducted several experiments to ensure that the response
generated in reconstituted mice after LN grafting was allospe-
cific. Naı¨ve BALB/c animals receiving CLNs from hosts that had
rejection of their B6 grafts were challenged, either with
C57BL/6-derived or third-party C3H-derived splenocytes (Fig.
5). Negative control animals were naı¨ve, and positive control
animals were BALB/c mice that were SC immunized to either
B6 or C3H antigens before challenge. Ear swelling was mea-
sured at 24 and 48 hours after challenge in all cases to assay for
allospecific DTH. CLN2/1 hosts reconstituted with CLNs from
mice that had shown rejection of B6 corneal grafts exhibited
strong allospecific DTH to a B6 splenocyte challenge similar to
that seen in positive control animals (Fig. 5A, P , 0.05). By
contrast, the DTH response of similarly reconstituted mice to
third-party C3H splenocytes was indistinguishable from that
seen in negative control animals and was significantly lower
than in positive control animals (Fig. 5B, P , 0.0002).
DISCUSSION
The ocular anterior segment is considered to be an immune
privileged site.13 The anterior chamber can elicit a unique
immune response, anterior chamber–associated immune devi-
ation (ACAID), that involves generation of regulatory cells
believed to be responsible in part,14–16 but not exclusively,17
for the prolonged survival enjoyed by many corneal grafts
compared with other solid organ transplants. This tolerance-
induced response, characterized by a systemic suppression of
antigen-specific DTH to ocularly delivered antigens, is called
deviant, because it is distinct from the immunizing response
generated to antigens at non–immune-privileged sites.13
However, the totality of immune mechanisms involved in
downmodulating the immune response to ocularly delivered
antigens is still insufficient to entirely suppress the generation
of T-helper 1 (Th1) cell–mediated alloimmunity.13–15 In fact,
Sonoda and Streilein16 and Yamada et al.18 have shown that
recipients of corneal grafts universally acquire donor-specific
DTH within several weeks of transplantation. It is interesting,
however, that although generation of DTH alloreactivity does
not necessarily lead to graft rejection,10,14–16 several laborato-
ries have independently shown that strategies that suppress
induction of donor-specific DTH are very effective in promot-
ing corneal graft survival.14,18–19 These observations have led
us18,19 and others14,15 to conclude that generation of allospe-
cific DTH is probably a necessary, albeit insufficient, facet of
FIGURE 5. LN reconstitution led to adoptive transfer of allospecific
immunity. Reconstituted CLN2/1 mice recipients of LNs from BALB/c
mice that had rejection of their C57BL/6 corneal grafts were chal-
lenged with C57BL/6 (A) or with C3H (B) splenocytes. Naı¨ve animals
served as negative control animals, and BALB/c SC immunized with
C57BL/6 (A) or C3H (B) splenocytes before challenge served as posi-
tive control animals. Results demonstrate that the adoptive transfer of
alloreactivity to reconstituted CLN2/1 mice was allospecific (A; *P ,
0.05) and did not extend to third-party C3H antigens (B; **P , 0.0002).
FIGURE 4. Graft survival in reconstituted host recipients of trans-
planted LNs derived from corneal graft recipients. Kaplan–Meier
survival analysis of C57BL/6 corneal transplants in the following
BALB/c hosts: Control, naı¨ve control animals; Acc LN TP, immu-
nized to donor splenocytes; Rej LN TP, recipients of CLNs from
corneal graft recipients that had had previous rejection of corneal
allografts; and Immunized, recipients of CLNs from hosts in which
corneal allografts were accepted. Of the hosts that were either naı¨ve
or that had received CLN transplants from mice with accepted
corneal allografts, 60% had acceptance of their corneal grafts. In
contrast, allografts in hosts that were either presensitized or that
were reconstituted with CLNs from rejector mice underwent swift
and universal rejection (P 5 0.0017).
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allorejection, because not all hosts that are sensitized eventu-
ally have rejection of their corneal grafts. Corneal transplant
rejection ultimately also requires effective recruitment of
primed alloreactive Th1 cells to the ocular anterior seg-
ment.12,15 Critical facets of ocular immune privilege, however,
such as generation of regulatory cells in the spleen and active
CD95-mediated killing of alloreactive T cells in the ocular
microenvironment can temper the allodestructive response in
the host,11,13,16,20,21 thereby offering corneal grafts a better
chance of success than that of other solid organ transplants.
The classic work of Billingham et al.22 demonstrated the
critical role of draining LNs in skin alloimmunity years before
the specific role of T cells in solid organ graft rejection was
appreciated. It is therefore surprising that, until recently, very
little attention has been paid to the role of the draining LNs in
the immunity generated in response to corneal transplantation.
It is known that the unique immune response generated to
ocularly delivered antigens, including corneal transplants, is
due, at least in part, to ocular antigens and antigen-presenting
cells (APCs) bypassing the lymph nodes and gaining access to
the systemic (venous) blood supply and priming tolerogenic
cells in the spleen.13,23,24 Although Ksander et al.9 have clearly
demonstrated generation of self-restricted donor minor histo-
compatibility (H)–reactive cytotoxic T cells in the draining LNs
of high-risk murine corneal allografts, other studies have failed
to demonstrate an important role for cytotoxicity in corneal
graft rejection,15,25,26 and the contribution of these observa-
tions to transplant rejection therefore remains unclear.
More recently, Kuffova et al.27 have demonstrated a CD40-
dependent dendritic cell–driven activation of host T cells after
murine corneal transplantation, but the antigen specificity of
these cells or their functional role in corneal graft rejection
have not yet been elucidated. Therefore, although generation
of an alloresponse in the draining LNs of eyes after corneal
transplantation is now established, its contribution to graft
rejection is still poorly understood. Our data from CLN2 mice
clearly demonstrate that corneal grafts in mice devoid of drain-
ing LNs enjoyed universal and indefinite survival (Fig. 1). The
enhanced survival of grafts in CLN2 hosts is associated with
failure in the induction of allospecific DTH reactivity (Fig. 2).
Taken together with the observation by other laboratories that
DTH-mediated mechanisms are critical in the rejection of cor-
neal allografts,10,13–16,18,25,26 our data suggest that the genera-
tion of allospecific and graft-destructive DTH is dependent
on functional lymphatic flow to the draining CLNs. It is
now clearly established, by the work of several groups associ-
ated with the laboratories of Niederkorn11,14,26 and
Streilein13,23,24,28 that regulatory allospecific graft-protective
responses are generated in the spleen after corneal transplan-
tation, and that disruption of the oculosplenic axis can have a
deleterious effect on graft outcome, as reflected by our data
demonstrating enhanced graft rejection rates in splenecto-
mized hosts compared with either naı¨ve control animals or
CLN2 hosts (Fig. 1).
The strong link between draining CLNs and generation of
DTH-type allodestructive immunity, and not tolerance, is sup-
ported, not only by data demonstrating universal graft survival
in CLN2 mice, but also by our observation (data not shown) of
an intact ACAID response to ocular antigens in CLN2 mice,
suggesting that LN-deficient mice are still competent in the
promotion of tolerance to intracameral antigens. Thus, we
explain the enhanced survival of allografts in CLN2/Sp2 hosts
by proposing that the interruption of the normal lymphatic
drainage from the eye in these hosts and thus of allosensitiza-
tion, as reflected by failure in generation of donor-specific
DTH, circumvents the critical need for (spleen-dependent)
induction of tolerance in promoting graft survival and thereby
renders CLN2/Sp2 hosts less susceptible to any deleterious
effect of splenectomy per se on transplant survival (Fig. 1).
Finally, reconstitution of CLN2 mice by transfer of LNs from
hosts with corneal grafts of long-standing acceptance failed to
demonstrate any added protection from corneal graft rejection
compared with normal naı¨ve hosts (Fig. 4). Conversely, recon-
stitution with LNs from hosts that had rejection of their corneal
grafts led to swift rejection of subsequent corneal transplants,
suggesting successful adoptive transfer of allodestructive, but
not alloprotective, responses. As such, transfer of Th1-medi-
ated alloreactivity by LN reconstitution is similar to the adop-
tive transfer of allospecific tolerance to naı¨ve mice by transfer
of ACAID-inducing splenic cells from hosts with long-standing
accepted grafts as described by Streilein,24 Niederkorn,26 and
Sano et al.28
Notwithstanding the evidence from our data that relates
draining LNs to allosensitization, we cannot theoretically rule
out the possibility that a population of regulatory T cells may
still be generated in the LNs that migrate subsequently to other
secondary lymphoid organs, including the spleen, for expan-
sion and recirculation. Because we tested the effect of recon-
stituting mice with LNs derived from hosts with graft accep-
tance 8 weeks after surgery (and noted no difference in
subsequent corneal graft survival compared with naı¨ve hosts),
it is possible that the functional contribution of these putative
LN-derived regulatory cells could not be assayed so late after
transplantation, because these cells may have already entered
the systemic circulation.
We found that nodes transplanted to the cervical chain
demonstrate re-established normal afferent lymph flow from
the eye by 4 weeks after transplantation. This differs only
slightly with the findings of Wolvers et al.,7 who reported that
it takes 3 weeks to recover normal afferent flow from the nasal
mucosa to grafted CLNs. However, they determined that the
cervical nodes that directly drain the nasal mucosa, but not the
peripheral nodes, constitute a unique environment that favors
immunologic tolerance to nasally administered antigens. Perez
et al. have recently shown that there is impaired induction of
Th1 response in the draining LNs of eyes intracamerally in-
jected with soluble antigen.29 These findings are in contrast to
the data presented herein, with which we have shown that
draining cervical LNs, regardless of their origin, demonstrate
alloimmune responses including allospecific DTH and graft
rejection.
The reasons that the draining LNs in one instance (in
response to soluble antigens introduced through the nasal
mucosa or anterior chamber) are related to tolerance and in
the other (in response to transplantation antigens in corneal
allografts) to Th1 immunization cannot be directly ad-
dressed by our data. It is possible that obvious differences
between the soluble antigens (e.g., ovalbumin) tested by
both Wolvers et al.7 and Perez et al.29 and transplantation
antigens operative in our model profoundly affect the nature
of the immune response generated.30 This is not altogether
unlikely: Recent studies in our laboratory31 have shown
that induction of tolerance to transplant antigens is more
difficult than to soluble antigens injected into the anterior
chamber.
In summary, in contrast to the extensively studied ocu-
losplenic venous-dependent antigen and APC traffic that
primes tolerance to ocular antigens, our data implicate func-
tional flow to draining CLNs as a necessary component of
alloimmunity and graft rejection in corneal transplantation.
Further studies are required to better characterize the molec-
ular facets of immunity that lead to allodestructive immuniza-
tion in the case of draining LNs and transplant tolerance in the
case of the spleen.
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